Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.
- Authors
- Allen, Nicole C; Bagade, Sachin; McQueen, Matthew B; Ioannidis, John P A; Kavvoura, Fotini K; Khoury, Muin J; Tanzi, Rudolph E; Bertram, Lars
- Year
- 2008
- Journal
- Nature genetics
- PMID
- 18583979
- DOI
- 10.1038/ng.171
In an effort to pinpoint potential genetic risk factors for schizophrenia, research groups worldwide have published over 1,000 genetic association studies with largely inconsistent results. To facilitate the interpretation of these findings, we have created a regularly updated online database of all published genetic association studies for schizophrenia ('SzGene'). For all polymorphisms having genotype data available in at least four independent case-control samples, we systematically carried out random-effects meta-analyses using allelic contrasts. Across 118 meta-analyses, a total of 24 genetic variants in 16 different genes (APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53 and TPH1) showed nominally significant effects with average summary odds ratios of approximately 1.23. Seven of these variants had not been previously meta-analyzed. According to recently proposed criteria for the assessment of cumulative evidence in genetic association studies, four of the significant results can be characterized as showing 'strong' epidemiological credibility. Our project represents the first comprehensive online resource for systematically synthesized and graded evidence of genetic association studies in schizophrenia. As such, it could serve as a model for field synopses of genetic associations in other common and genetically complex disorders.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Neuronal guidance signaling in neurodegenerative diseases: Key regulators that function at neuron-glia and neuroimmune interfaces. | Yuasa-Kawada J et al. | β | 2026 | β |
| Candidate Genetic Markers of Schizophrenia Based on Exome Sequencing Data and Its Relation to Immunological, Clinical, and Morphometric Changes in the Russian Population. | Rastorguev SM et al. | β | 2025 | β |
| Dizocilpine Does Not Alter <i>NOS1AP</i> Gene Expression in Rats and in Cell Cultures. | Matiiv AB et al. | β | 2025 | β |
| Is there a causal link between folate status and schizophrenia? Evidence from genetic association studies. | Yoo S et al. | β | 2025 | β |
| Tryptophan Hydroxylase 1 Regulates Tryptophan and Its Metabolites. | Nonogaki K et al. | β | 2025 | β |
| Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism. | Wang L et al. | β | 2024 | β |
| Association of 11 variants of the dopaminergic and cognitive pathways genes with major depression, schizophrenia and bipolar disorder in the Pakistani population. | Nasir Hashmi A et al. | β | 2024 | β |
| Association of <i>NOTCH4</i> and <i>CYP2E1</i> Genetic Variants With Schizophrenia in the Bangladeshi Population: A Case-Control Study. | Millat MS et al. | β | 2024 | β |
| Discovering functional interactions among schizophrenia-risk genes by combining behavioral genetics with cell biology. | Ma D et al. | β | 2024 | β |
| Evaluation of gene-gene interaction between the interleukin (IL)-2 and IL-2RA gene polymorphisms in schizophrenia patients in the Turkish Population. | Ozdilli K et al. | β | 2024 | β |
| Genetic polymorphisms and their association with neurobiological and psychological factors in anorexia nervosa: a systematic review. | Almaghrbi H et al. | β | 2024 | β |
| Grid1 regulates the onset of puberty in female rats. | Ye J et al. | β | 2024 | β |
| New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment. | Faris P et al. | β | 2024 | β |
| Pan-ErbB inhibition impairs cognition via disrupting myelination and aerobic glycolysis in oligodendrocytes. | Hu X et al. | β | 2024 | β |
| Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes. | Peall KJ et al. | β | 2024 | β |
| Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches toΒ insights of susceptibility genes. | Lv Y et al. | β | 2024 | β |
| Schizotypal traits and their relationship to reading abilities in healthy adults. | Byers N et al. | β | 2024 | β |
| Alternative splicing in mouse brains affected by psychological stress is enriched in the signaling, neural transmission and blood-brain barrier pathways. | Wang F et al. | β | 2023 | β |
| Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model. | Hampel H et al. | β | 2023 | β |
| <i>APOEΞ΅4</i> and risk of Alzheimer's disease - time to move forward. | Lefterov I et al. | β | 2023 | β |
| Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia. | Medina AM et al. | β | 2023 | β |
| Prioritizing genes associated with brain disorders by leveraging enhancer-promoter interactions in diverse neural cells and tissues. | Zhao X et al. | β | 2023 | β |
| Progressive trajectories of schizophrenia across symptoms, genes, and the brain. | Jiang S et al. | β | 2023 | β |
| Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures. | Ahmed M et al. | β | 2023 | β |
| Adult neural stem cells and schizophrenia. | Hu L et al. | β | 2022 | β |
| [Association of gene polymorphisms DRD3 rs6280, COMT rs4680 and HTR2A rs7322347 with schizophrenia]. | Sofronov AG et al. | β | 2022 | β |
| Association of Variants in <i>COMT, RASSF1</i> and <i>GPM6A</i> with the Risk of Paranoid Schizophrenia Patients in Prof HB Saanin Psychiatric Hospital, West Sumatra, Indonesia. | Yunaini L et al. | β | 2022 | β |
| Autism and ADHD in the Era of Big Data; An Overview of Digital Resources for Patient, Genetic and Clinical Trials Information. | Abomelha FM et al. | β | 2022 | β |
| Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. | MΓ€tlik K et al. | β | 2022 | β |
| Functional Variants of miR-143 Are Associated with Schizophrenia Susceptibility: A Preliminary Population-Based Study and Bioinformatics Analysis. | Sargazi S et al. | β | 2022 | β |
| Genetic architecture of tuberculosis susceptibility: A comprehensive research synopsis, meta-analyses, and epidemiological evidence. | Jiao L et al. | β | 2022 | β |
| Genetic evidence for association of <i>NOTCH4</i> variant rs2071287 with schizophrenia susceptibility in the North Indian population. | Priya I et al. | β | 2022 | β |
| Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity. | Shnayder NA et al. | β | 2022 | β |
| Immunologic profiling in schizophrenia and rheumatoid arthritis. | Eaton WW et al. | β | 2022 | β |
| New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3, CSMD1 and NRG1 genes. | Mestiri S et al. | β | 2022 | β |
| Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. | Notaras M et al. | β | 2022 | β |
| Top2a promotes the development of social behavior via PRC2 and H3K27me3. | Geng Y et al. | β | 2022 | β |
| Agonal Factors Distort Gene-Expression Patterns in Human Postmortem Brains. | Dai J et al. | β | 2021 | β |
| A Rare Case of Brachyolmia with Amelogenesis Imperfecta Caused by a New Pathogenic Splicing Variant in <i>LTBP3</i>. | Flex E et al. | β | 2021 | β |
| Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis. | Ma J et al. | β | 2021 | β |
| Association study of six candidate genes with major depressive disorder in the North-Western population of Pakistan. | Alam N et al. | β | 2021 | β |
| ASSOCIATION STUDY OF SIX CANDIDATE GENES WITH MAJOR DEPRESSIVE DISORDER IN THE NORTH-WESTERN POPULATION OF PAKISTAN | Alam N et al. | β | 2021 | β |
| Astrocytes in schizophrenia. | Notter T | β | 2021 | β |
| Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome. | Greening DW et al. | β | 2021 | β |
| Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex. | Toriumi K et al. | β | 2021 | β |
| Cortical copper transporter expression in schizophrenia: interactions of risk gene dysbindin-1. | Schoonover KE et al. | β | 2021 | β |
| Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia. | Pei JC et al. | β | 2021 | β |
| Distinct epigenetic signatures between adult-onset and late-onset depression. | Yamagata H et al. | β | 2021 | β |
| Distinct placental molecular processes associated with early-onset and late-onset preeclampsia. | Ren Z et al. | β | 2021 | β |
| Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese. | Shen L et al. | β | 2021 | β |
| Glyoxalase 1 Confers Susceptibility to Schizophrenia: From Genetic Variants to Phenotypes of Neural Function. | Yin J et al. | β | 2021 | β |
| Identifying age-specific gene signatures of the human cerebral cortex with joint analysis of transcriptomes and functional connectomes. | Zhao X et al. | β | 2021 | β |
| Low-Level Brain Somatic Mutations Are Implicated in Schizophrenia. | Kim MH et al. | β | 2021 | β |
| Multiplex gene and phenotype network to characterize shared genetic pathways of epilepsy and autism. | Peng J et al. | β | 2021 | β |
| Myospryn deficiency leads to impaired cardiac structure and function and schizophrenia-associated symptoms. | Tsoupri E et al. | β | 2021 | β |
| Negative symptoms in schizophrenia: correlation with clinical and genetic factors. | Hajj A et al. | β | 2021 | β |
| nMAGMA: a network-enhanced method for inferring risk genes from GWAS summary statistics and its application to schizophrenia. | Yang A et al. | β | 2021 | β |
| Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews. | Mentis AA et al. | β | 2021 | β |
| Paternal age affects offspring via an epigenetic mechanism involving REST/NRSF. | Yoshizaki K et al. | β | 2021 | β |
| Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review. | Wagh VV et al. | β | 2021 | β |
| Precision and personalized assessment, diagnosis and treatment in psychiatry. | Fountoulakis KN et al. | β | 2021 | β |
| Response to the Letter to the Editor concerning 'Evolutionary puzzle of Toxoplasma gondii with suicidal ideation and suicide attempts: An updated systematic review and meta-analysis' by Amouei et al. (Transbound Emerg Dis; 2020: Https://doi.org/10.1111/tbed.13550). | Amouei A et al. | β | 2021 | β |
| Serum level of high sensitive C-reactive protein and IL -β6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study. | Challa F et al. | β | 2021 | β |
| Sex-differential DNA methylation and associated regulation networks in human brain implicated in the sex-biased risks of psychiatric disorders. | Xia Y et al. | β | 2021 | β |
| Abnormal dynamic resting-state brain network organization in auditory verbal hallucination. | Geng H et al. | β | 2020 | β |
| Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain. | Schmidt-Kastner R et al. | β | 2020 | β |
| Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia. | Michalczyk A et al. | β | 2020 | β |
| Association of SOX11 Polymorphisms in distal 3'UTR with Susceptibility for Schizophrenia. | Sun CP et al. | β | 2020 | β |
| Association of the CACNA2D2 gene with schizophrenia in Chinese Han population. | Fu Y et al. | β | 2020 | β |
| Genetic variants in dopamine receptors influence on heterodimerization in the context of antipsychotic drug action. | Faron-GΓ³recka A et al. | β | 2020 | β |
| GRIN2B Gene Polymorphism in Chronic Ketamine Users. | Fan N et al. | β | 2020 | β |
| Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice. | Schoonover KE et al. | β | 2020 | β |
| Meta-analysis and field synopsis of genetic variants associated with the risk and severity of acute pancreatitis. | van den Berg FF et al. | β | 2020 | β |
| Pharmacogenomic Biomarkers and Their Applications in Psychiatry. | Kam H et al. | β | 2020 | β |
| Relationship between Single Nucleotide Polymorphisms of <i>GRHL3</i> and Schizophrenia Susceptibility: A Preliminary Case-Control Study and Bioinformatics Analysis. | Sargazi S et al. | β | 2020 | β |
| Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report. | Amir QU et al. | β | 2020 | β |
| Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. | Montazeri Z et al. | β | 2020 | β |
| SZDB2.0: an updated comprehensive resource for schizophrenia research. | Wu Y et al. | β | 2020 | β |
| The association of GABRB2 SNPs with cognitive function in schizophrenia. | Zhang Q et al. | β | 2020 | β |
| The genetics of bipolar disorder. | Gordovez FJA et al. | β | 2020 | β |
| [The study of the association between the C677T polymorphism of the methylenetetrahydrofolate reductase gene and severity of symptoms in patients with schizophrenia]. | Korovaitseva GI et al. | β | 2020 | β |
| Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations. | Liu H et al. | β | 2020 | β |
| Acute stress-induced change in polysialic acid levels mediated by sialidase in mouse brain. | Abe C et al. | β | 2019 | β |
| A Fast and Flexible Framework for Network-Assisted Genomic Association. | Carlin DE et al. | β | 2019 | β |
| A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 4: Evidence from chromosome 4 high-density association screen. | Tang J et al. | β | 2019 | β |
| Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders. | Feltrin AS et al. | β | 2019 | β |
| Association between the <i>SLC6A4</i> gene and schizophrenia: an updated meta-analysis. | Xu FL et al. | β | 2019 | β |
| Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type? | Bygrave AM et al. | β | 2019 | β |
| Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study. | Hajj A et al. | β | 2019 | β |
| Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond. | Waddington JL et al. | β | 2019 | β |
| Distinctive Roles of D-Amino Acids in the Homochiral World: Chirality of Amino Acids Modulates Mammalian Physiology and Pathology. | Sasabe J et al. | β | 2019 | β |
| Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling. | Liu Z et al. | β | 2019 | β |
| Elevated cleavage of neuregulin-1 by beta-secretase 1 in plasma of schizophrenia patients. | Zhang Z et al. | β | 2019 | β |
| Multi-scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients. | Ma L et al. | β | 2019 | β |
| Over-expression of TGF-Ξ²1 gene in medication free Schizophrenia. | Amoli MM et al. | β | 2019 | β |
| Pathway-specific protein domains are predictive for human diseases. | Shim JE et al. | β | 2019 | β |
| Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes. | He Y et al. | β | 2019 | β |
| Reduced cortical thickness related to single nucleotide polymorphisms in the major histocompatibility complex region in antipsychotic-naive schizophrenia. | Tao B et al. | β | 2019 | β |
| Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. | Avram M et al. | β | 2019 | β |
| Strategies for Network GWAS Evaluated Using Classroom Crowd Science. | Fong SH et al. | β | 2019 | β |
| Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates. | Quan Y et al. | β | 2019 | β |
| The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies. | Liu C et al. | β | 2019 | β |
| TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population. | Yang J et al. | β | 2019 | β |
| Translational bioinformatics in mental health: open access data sources and computational biomarker discovery. | Tenenbaum JD et al. | β | 2019 | β |
| A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. | Sakamoto K et al. | β | 2018 | β |
| Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia. | Xu L et al. | β | 2018 | β |
| A meta-analysis of data associating <i>DRD4</i> gene polymorphisms with schizophrenia. | Xu FL et al. | β | 2018 | β |
| Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects. | Rampino A et al. | β | 2018 | β |
| [A role of the immune system in the pathogenesis of schizophrenia]. | Malashenkova IK et al. | β | 2018 | β |
| Astrocytic Regulation of Glutamate Transmission in Schizophrenia. | Mei YY et al. | β | 2018 | β |
| A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia. | Jagannath V et al. | β | 2018 | β |
| Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects. | Kim Y et al. | β | 2018 | β |
| Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes. | Yang CP et al. | β | 2018 | β |
| Convergent roles of de novo mutations and common variants in schizophrenia in tissue-specific and spatiotemporal co-expression network. | Jia P et al. | β | 2018 | β |
| DNA Methylation and Psychiatric Disorders. | Liu C et al. | β | 2018 | β |
| Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons. | Wang P et al. | β | 2018 | β |
| Evolutionary and genetic features of drug targets. | Quan Y et al. | β | 2018 | β |
| Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders. | Hoffmann C et al. | β | 2018 | β |
| Further evidence for the genetic association between <i>CACNA1I</i> and schizophrenia. | Xie Y et al. | β | 2018 | β |
| <i>COMT, 5-HTR2A</i>, and <i>SLC6A4</i> mRNA Expressions in First-Episode Antipsychotic-NaΓ―ve Schizophrenia and Association With Treatment Outcomes. | Li Z et al. | β | 2018 | β |
| Integrating Imaging Genomic Data in the Quest for Biomarkers of Schizophrenia Disease. | Su-Ping Deng et al. | β | 2018 | β |
| Loss of Sfpq Causes Long-Gene Transcriptopathy in the Brain. | Takeuchi A et al. | β | 2018 | β |
| Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK). | Taalab YM et al. | β | 2018 | β |
| Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA/polySia) and the synthesizing enzyme, ST8SIA2. | Sato C et al. | β | 2018 | β |
| Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium. | Zhang T et al. | β | 2018 | β |
| Modelling the neuromotor abnormalities of psychotic illness: Putative mechanisms and systems dysfunction. | Waddington JL et al. | β | 2018 | β |
| Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease. | Liu Y et al. | β | 2018 | β |
| Paternal and maternal age as risk factors for schizophrenia: a case-control study. | Fountoulakis KN et al. | β | 2018 | β |
| Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis. | JΓ©zΓ©quel J et al. | β | 2018 | β |
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | Dick DM et al. | β | 2018 | β |
| Reagent Validation to Facilitate Experimental Reproducibility. | Williams M | β | 2018 | β |
| Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. | Belbasis L et al. | β | 2018 | β |
| Species-Specific Changes in a Primate Transcription Factor Network Provide Insights into the Molecular Evolution of the Primate Prefrontal Cortex. | Berto S et al. | β | 2018 | β |
| The evolution of a series of behavioral traits is associated with autism-risk genes in cavefish. | Yoshizawa M et al. | β | 2018 | β |
| The Response Patterns of Arbuscular Mycorrhizal and Ectomycorrhizal Symbionts Under Elevated CO<sub>2</sub>: A Meta-Analysis. | Dong Y et al. | β | 2018 | β |
| The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies. | Quagliato LA et al. | β | 2018 | β |
| Weighted mining of massive collections of [Formula: see text]-values by convex optimization. | Dobriban E | β | 2018 | β |
| A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia. | Rao W et al. | β | 2017 | β |
| ALDH2 Glu504Lys Confers Susceptibility to Schizophrenia and Impacts Hippocampal-Prefrontal Functional Connectivity. | Zheng F et al. | β | 2017 | β |
| An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects. | Siekmeier PJ | β | 2017 | β |
| A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen. | Chen X et al. | β | 2017 | β |
| A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen. | Chen X et al. | β | 2017 | β |
| A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density. | Liu S et al. | β | 2017 | β |
| A review of molecular genetic studies of neurocognitive deficits in schizophrenia. | Zai G et al. | β | 2017 | β |
| Association between RGS4 variants and psychotic-like experiences in nonclinical individuals. | de Castro-Catala M et al. | β | 2017 | β |
| Attempts to replicate genetic associations with schizophrenia in a cohort from north India. | Prasad S et al. | β | 2017 | β |
| BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo. | Zhang W et al. | β | 2017 | β |
| Brain structure in women at risk of postpartum psychosis: an MRI study. | FustΓ© M et al. | β | 2017 | β |
| Characteristics of allelic gene expression in human brain cells from single-cell RNA-seq data analysis. | Zhao D et al. | β | 2017 | β |
| Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View. | Jagannath V et al. | β | 2017 | β |
| CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. | Wang P et al. | β | 2017 | β |
| Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes. | Petit EI et al. | β | 2017 | β |
| EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality. | Bailey JN et al. | β | 2017 | β |
| Enhancing reproducibility: Failures from Reproducibility Initiatives underline core challenges. | Mullane K et al. | β | 2017 | β |
| Expression of D-Amino Acid Oxidase (<i>DAO</i>/<i>DAAO</i>) and D-Amino Acid Oxidase Activator (<i>DAOA/G72</i>) during Development and Aging in the Human Post-mortem Brain. | Jagannath V et al. | β | 2017 | β |
| Geographical and ethnic distribution of MTHFR gene polymorphisms and their associations with diseases among Chinese population. | Yang B et al. | β | 2017 | β |
| GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients. | Pinheiro DS et al. | β | 2017 | β |
| GWAB: a web server for the network-based boosting of human genome-wide association data. | Shim JE et al. | β | 2017 | β |
| Habituation is altered in neuropsychiatric disorders-A comprehensive review with recommendations for experimental design and analysis. | McDiarmid TA et al. | β | 2017 | β |
| How Good Were Candidate Gene Guesses in Schizophrenia Genetics? | Sullivan PF | β | 2017 | β |
| Integrative Analysis to Identify Common Genetic Markers of Metabolic Syndrome, Dementia, and Diabetes. | Zhang W et al. | β | 2017 | β |
| Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis. | Rai V et al. | β | 2017 | β |
| Mining databases for protein aggregation: a review. | Tsiolaki PL et al. | β | 2017 | β |
| Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity. | Hsu KC et al. | β | 2017 | β |
| No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes. | Johnson EC et al. | β | 2017 | β |
| Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. | Liu C et al. | β | 2017 | β |
| Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines. | Taraskina AE et al. | β | 2017 | β |
| Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of <i>DAO, DAOA</i>, and <i>NRG1</i> Variants with Negative Symptoms and Cognitive Deficits. | Jagannath V et al. | β | 2017 | β |
| Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia. | Kort NS et al. | β | 2017 | β |
| SZDB: A Database for Schizophrenia Genetic Research. | Wu Y et al. | β | 2017 | β |
| The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis. | Liu YS et al. | β | 2017 | β |
| The effect of <i>COMT Val158Met</i> and <i>DRD2 C957T</i> polymorphisms on executive function and the impact of early life stress. | Klaus K et al. | β | 2017 | β |
| Theranostic Biomarkers for Schizophrenia. | Perkovic MN et al. | β | 2017 | β |
| Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. | O'Tuathaigh CMP et al. | β | 2017 | β |
| Translational Genetic Modelling of 3D Craniofacial Dysmorphology: Elaborating the Facial Phenotype of Neurodevelopmental Disorders Through the "Prism" of Schizophrenia. | Waddington JL et al. | β | 2017 | β |
| Tumor necrosis factor-Ξ± and -Ξ² genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. | Kadasah S et al. | β | 2017 | β |
| Verbal memory improvement in first-episode psychosis <i>APOE</i>-Ξ΅4 carriers: a pleiotropic effect? | Vila-Rodriguez F et al. | β | 2017 | β |
| A Consensus Network of Gene Regulatory Factors in the Human Frontal Lobe. | Berto S et al. | β | 2016 | β |
| A network of synaptic genes associated with schizophrenia and bipolar disorder. | Forero DA et al. | β | 2016 | β |
| A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity. | Huang T et al. | β | 2016 | β |
| A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics. | Baou M et al. | β | 2016 | β |
| A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies. | Malt EA et al. | β | 2016 | β |
| A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. | Cohen OS et al. | β | 2016 | β |
| Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China. | Yang G et al. | β | 2016 | β |
| Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients. | Bakanidze G et al. | β | 2016 | β |
| Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies. | Feng Y et al. | β | 2016 | β |
| Association of toll-like receptor 3 polymorphism rs3775291 with age-related macular degeneration: a systematic review and meta-analysis. | Ma L et al. | β | 2016 | β |
| A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia. | Malan-MΓΌller S et al. | β | 2016 | β |
| Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk. | Kinoshita M et al. | β | 2016 | β |
| Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation. | Butler MG et al. | β | 2016 | β |
| dbAARD & AGP: A computational pipeline for the prediction of genes associated with age related disorders. | Srivastava I et al. | β | 2016 | β |
| Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood. | Chen CH | β | 2016 | β |
| Does COMT val158met polymorphism influence P50 sensory gating, eye tracking or saccadic inhibition dysfunctions in schizophrenia? | Demily C et al. | β | 2016 | β |
| Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia. | Gaskin PL et al. | β | 2016 | β |
| Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia. | Lee SA et al. | β | 2016 | β |
| Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study. | Edwards AC et al. | β | 2016 | β |
| Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder. | Clelland CL et al. | β | 2016 | β |
| Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk. | Kos MZ et al. | β | 2016 | β |
| Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. | Serghiou S et al. | β | 2016 | β |
| From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. | Cariaga-Martinez A et al. | β | 2016 | β |
| G72 primate-specific gene: a still enigmatic element in psychiatric disorders. | Sacchi S et al. | β | 2016 | β |
| Genetic Associations of Primary Angle-Closure Disease: A Systematic Review and Meta-analysis. | Rong SS et al. | β | 2016 | β |
| GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia. | Sapkota K et al. | β | 2016 | β |
| Imagination in human social cognition, autism, and psychotic-affective conditions. | Crespi B et al. | β | 2016 | β |
| Investigating the structural impact of S311C mutation in DRD2 receptor by molecular dynamics & docking studies. | Podder A et al. | β | 2016 | β |
| Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior. | Dries DR et al. | β | 2016 | β |
| Meta-analysis of sex differences in gene expression in schizophrenia. | Qin W et al. | β | 2016 | β |
| Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia. | Takano Y et al. | β | 2016 | β |
| Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. | Mokhtari M et al. | β | 2016 | β |
| Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: An updated meta-analysis. | Yadav U et al. | β | 2016 | β |
| Screening of reproduction-related single-nucleotide variations from MeDIP-seq data in sheep. | Cao J et al. | β | 2016 | β |
| Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. | Montazeri Z et al. | β | 2016 | β |
| Systems psychopharmacology: A network approach to developing novel therapies. | Gebicke-Haerter PJ | β | 2016 | β |
| The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia. | Ju P et al. | β | 2016 | β |
| The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia. | Maj C et al. | β | 2016 | β |
| The SNP rs1625579 in miR-137 gene and risk of schizophrenia in Chinese population: A meta-analysis. | Zhang P et al. | β | 2016 | β |
| Transcranial direct current stimulation and neuroplasticity genes: implications for psychiatric disorders. | Chhabra H et al. | β | 2016 | β |
| Triangulating meta-analyses: the example of the serotonin transporter gene, stressful life events and major depression. | Taylor AE et al. | β | 2016 | β |
| [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia]. | Huertas-RodrΓguez CK et al. | β | 2015 | β |
| A comparative study of disease genes and drug targets in the human protein interactome. | Sun J et al. | β | 2015 | β |
| A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: a case-control study. | Zhang XY et al. | β | 2015 | β |
| Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. | Dawson N et al. | β | 2015 | β |
| A molecular pathway analysis informs the genetic background at risk for schizophrenia. | Crisafulli C et al. | β | 2015 | β |
| A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia. | Matsuno H et al. | β | 2015 | β |
| A novel relationship for schizophrenia, bipolar and major depressive disorder Part 7: A hint from chromosome 7 high density association screen. | Chen X et al. | β | 2015 | β |
| Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. | Abdolmaleky HM et al. | β | 2015 | β |
| Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis. | Al-Asmary SM et al. | β | 2015 | β |
| A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. | Brand SJ et al. | β | 2015 | β |
| Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample. | Ramsay H et al. | β | 2015 | β |
| Association of the NOTCH4 Gene Polymorphism rs204993 with Schizophrenia in the Chinese Han Population. | Zhang B et al. | β | 2015 | β |
| Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population. | Yang Y et al. | β | 2015 | β |
| A systematic appraisal of field synopses in genetic epidemiology: a HuGE review. | Belbasis L et al. | β | 2015 | β |
| Biological factors underlying sex differences in neurological disorders. | Loke H et al. | β | 2015 | β |
| Childhood neglect predicts disorganization in schizophrenia through grey matter decrease in dorsolateral prefrontal cortex. | Cancel A et al. | β | 2015 | β |
| Clinical management of negative symptoms of schizophrenia: An update. | Tsapakis EM et al. | β | 2015 | β |
| Clock genes control cortical critical period timing. | Kobayashi Y et al. | β | 2015 | β |
| Common variants in the MKL1 gene confer risk of schizophrenia. | Luo XJ et al. | β | 2015 | β |
| Common variants of HTR1A and SLC6A4 confer the increasing risk of Schizophrenia susceptibility: A population-based association and epistasis analysis. | Lin H et al. | β | 2015 | β |
| Common variants of the PINK1 and PARL genes do not confer genetic susceptibility to schizophrenia in Han Chinese. | Li X et al. | β | 2015 | β |
| CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment. | Wang P et al. | β | 2015 | β |
| d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. | Pritchett D et al. | β | 2015 | β |
| Decoding Advances in Psychiatric Genetics: A Focus on Neural Circuits in Rodent Models. | Heckenast JR et al. | β | 2015 | β |
| Disrupted-in-Schizophrenia-1 SNPs and Susceptibility to Schizophrenia: Evidence from Malaysia. | Norlelawati AT et al. | β | 2015 | β |
| DNA methylation in psychosis: insights into etiology and treatment. | Castellani CA et al. | β | 2015 | β |
| Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders. | Yamaguchi Y et al. | β | 2015 | β |
| Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis. | Rosen AM et al. | β | 2015 | β |
| Epistasis in the risk of human neuropsychiatric disease. | Williams SM | β | 2015 | β |
| Evaluating historical candidate genes for schizophrenia. | Farrell MS et al. | β | 2015 | β |
| Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis. | Numata S et al. | β | 2015 | β |
| Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder. | Moises HW et al. | β | 2015 | β |
| Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis. | Wong KH et al. | β | 2015 | β |
| GRIN2B predicts attention problems among disadvantaged children. | Riva V et al. | β | 2015 | β |
| Heart rate variability as a transdiagnostic biomarker of psychopathology. | Beauchaine TP et al. | β | 2015 | β |
| Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia. | Joseph J et al. | β | 2015 | β |
| Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia. | Wang D et al. | β | 2015 | β |
| LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. | Mirendil H et al. | β | 2015 | β |
| Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis. | Chen CH et al. | β | 2015 | β |
| Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals. | Chang S et al. | β | 2015 | β |
| Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates. | Martin MV et al. | β | 2015 | β |
| Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice. | D'Agostino G et al. | β | 2015 | β |
| Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population. | Zhang Y et al. | β | 2015 | β |
| PRODH rs450046 and proline x COMT ValΒΉβ΅βΈ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome. | de Koning MB et al. | β | 2015 | β |
| Recent genetic findings in schizophrenia and their therapeutic relevance. | Harrison PJ | β | 2015 | β |
| Reducing peripheral serotonin turns up the heat in brown fat. | Carey AL et al. | β | 2015 | β |
| Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Samsom JN et al. | β | 2015 | β |
| Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. | Gatt JM et al. | β | 2015 | β |
| The current and potential impact of genetics and genomics on neuropsychopharmacology. | Harrison PJ | β | 2015 | β |
| The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. | Balu DT et al. | β | 2015 | β |
| Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease. | Caudle WM | β | 2015 | β |
| A literature search tool for intelligent extraction of disease-associated genes. | Jung JY et al. | β | 2014 | β |
| Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. | Chan MK et al. | β | 2014 | β |
| Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research. | Schmidt A et al. | β | 2014 | β |
| Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis. | Wu YL et al. | β | 2014 | β |
| Association between the NOTCH4 gene rs3131296 polymorphism with schizophrenia risk in the Chinese Zhuang population and Chinese Han population. | Su L et al. | β | 2014 | β |
| Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis. | Pan Y et al. | β | 2014 | β |
| Association of the PPAR-Ξ³ Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics. | Liu YR et al. | β | 2014 | β |
| Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome. | Gothelf D et al. | β | 2014 | β |
| B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. | Mitchell ES et al. | β | 2014 | β |
| Common variants on Xq28 conferring risk of schizophrenia in Han Chinese. | Wong EH et al. | β | 2014 | β |
| Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. | Kaalund SS et al. | β | 2014 | β |
| D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine. | Betts JF et al. | β | 2014 | β |
| Dissociable genetic contributions to error processing: a multimodal neuroimaging study. | Agam Y et al. | β | 2014 | β |
| DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia. | Numata S et al. | β | 2014 | β |
| D-Serine in neurobiology: CNS neurotransmission and neuromodulation. | Bardaweel SK et al. | β | 2014 | β |
| Dysbindin-associated proteome in the p2 synaptosome fraction of mouse brain. | Han MH et al. | β | 2014 | β |
| Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR). | Santoro ML et al. | β | 2014 | β |
| Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees. | Bousman CA et al. | β | 2014 | β |
| Enhanced prepulse inhibition and low sensitivity to a dopamine agonist in HESR1 knockout mice. | Kanno K et al. | β | 2014 | β |
| Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia. | Kocsis B et al. | β | 2014 | β |
| Evolutionary conservation in genes underlying human psychiatric disorders. | Ogawa LM et al. | β | 2014 | β |
| Exploring the indirect effects of catechol-O-methyltransferase (COMT) genotype on psychotic experiences through cognitive function and anxiety disorders in a large birth cohort of children. | Niarchou M et al. | β | 2014 | β |
| Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. | Monks S et al. | β | 2014 | β |
| Genetically modified mice related to schizophrenia and other psychoses: seeking phenotypic insights into the pathobiology and treatment of negative symptoms. | O'Tuathaigh CM et al. | β | 2014 | β |
| Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population. | Yao J et al. | β | 2014 | β |
| Genetic insight of schizophrenia: past and future perspectives. | Singh S et al. | β | 2014 | β |
| Genetics studies indicate that neural induction and early neuronal maturation are disturbed in autism. | Casanova EL et al. | β | 2014 | β |
| Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review. | Zhang X et al. | β | 2014 | β |
| Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. | Ma X et al. | β | 2014 | β |
| Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. | Soto D et al. | β | 2014 | β |
| How might ZNF804A variants influence risk for schizophrenia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis. | Hess JL et al. | β | 2014 | β |
| How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library. | Matheson SL et al. | β | 2014 | β |
| Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis. | Zhang C et al. | β | 2014 | β |
| Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models. | McOmish CE et al. | β | 2014 | β |
| Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements. | Beyan T et al. | β | 2014 | β |
| Inflammatory cytokine network in schizophrenia. | Zakharyan R et al. | β | 2014 | β |
| Lung cancer risk and genetic variants in East Asians: a meta-analysis. | Zhang Q et al. | β | 2014 | β |
| MCPerm: a Monte Carlo permutation method for accurately correcting the multiple testing in a meta-analysis of genetic association studies. | Jiang Y et al. | β | 2014 | β |
| Medial prefrontal cortex: genes linked to bipolar disorder and schizophrenia have altered expression in the highly social maternal phenotype. | Eisinger BE et al. | β | 2014 | β |
| Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. | Nishi A et al. | β | 2014 | β |
| miR-137: a new player in schizophrenia. | Yin J et al. | β | 2014 | β |
| Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia. | Pietersen CY et al. | β | 2014 | β |
| Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders. | Lotan A et al. | β | 2014 | β |
| Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. | Cristino AS et al. | β | 2014 | β |
| NPAS3 variants in schizophrenia: a neuroimaging study. | Bernier D et al. | β | 2014 | β |
| Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. | Hayashi-Takagi A et al. | β | 2014 | β |
| Positive symptoms in first-episode psychosis patients experiencing low maternal care and stressful life events: a pilot study to explore the role of the COMT gene. | Ira E et al. | β | 2014 | β |
| Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2. | Taurisano P et al. | β | 2014 | β |
| Risk genes for schizophrenia: translational opportunities for drug discovery. | Winchester CL et al. | β | 2014 | β |
| Role of COMT in ADHD: a systematic meta-analysis. | Sun H et al. | β | 2014 | β |
| Schizophrenia: an integrated sociodevelopmental-cognitive model. | Howes OD et al. | β | 2014 | β |
| Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. | Vassos E et al. | β | 2014 | β |
| Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. | Luo X et al. | β | 2014 | β |
| Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis. | Huang KC et al. | β | 2014 | β |
| Transcriptome-wide discovery of microRNA binding sites in human brain. | Boudreau RL et al. | β | 2014 | β |
| Understanding complex transcriptome dynamics in schizophrenia and other neurological diseases using RNA sequencing. | Wang X et al. | β | 2014 | β |
| Vitamin supplementation in the treatment of schizophrenia. | Brown HE et al. | β | 2014 | β |
| Abnormalities in extracellular glycine and glutamate levels in the striatum of sandy mice. | Kitaichi Y et al. | β | 2013 | β |
| A comprehensive family-based replication study of schizophrenia genes. | Aberg KA et al. | β | 2013 | β |
| A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia. | Yee BK et al. | β | 2013 | β |
| Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system. | Huang KC et al. | β | 2013 | β |
| An examination of auditory processing and affective prosody in relatives of patients with auditory hallucinations. | Tucker R et al. | β | 2013 | β |
| A population-specific uncommon variant in GRIN3A associated with schizophrenia. | Takata A et al. | β | 2013 | β |
| Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFΞ±) gene polymorphisms with paranoid schizophrenia in a Polish population. | Paul-Samojedny M et al. | β | 2013 | β |
| Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients. | Zhang Y et al. | β | 2013 | β |
| Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population. | Li W et al. | β | 2013 | β |
| BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder. | Chang SH et al. | β | 2013 | β |
| Chromosomal distribution of schizophrenia susceptibility loci. | Saadat M | β | 2013 | β |
| COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation. | Ira E et al. | β | 2013 | β |
| Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. | Hiroi N et al. | β | 2013 | β |
| DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity. | Callicott JH et al. | β | 2013 | β |
| Does the dopamine hypothesis explain schizophrenia? | Lau CI et al. | β | 2013 | β |
| Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia. | Grant P et al. | β | 2013 | β |
| Dopaminergic gene polymorphisms affect long-term forgetting in old age: further support for the magnification hypothesis. | Papenberg G et al. | β | 2013 | β |
| DRD2 haplotype associated with negative symptoms and sustained attention deficits in Han Chinese with schizophrenia in Taiwan. | Chien YL et al. | β | 2013 | β |
| Drosophila strategies to study psychiatric disorders. | van Alphen B et al. | β | 2013 | β |
| Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy. | Rangrez AY et al. | β | 2013 | β |
| Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. | Bousman CA et al. | β | 2013 | β |
| Elevated homocysteine level in siblings of patients with schizophrenia. | Geller V et al. | β | 2013 | β |
| Enzyme activity of the PIP4K2A gene product polymorphism that is implicated in schizophrenia. | Clarke JH et al. | β | 2013 | β |
| Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. | Del Pino I et al. | β | 2013 | β |
| Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. | Young JW et al. | β | 2013 | β |
| Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. | Hwang Y et al. | β | 2013 | β |
| Genes and environments in schizophrenia: The different pieces of a manifold puzzle. | RΓ©thelyi JM et al. | β | 2013 | β |
| Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield". | O'Tuathaigh CM et al. | β | 2013 | β |
| Genetics of schizophrenia: What do we know? | Zhang JP et al. | β | 2013 | β |
| Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. | Roffman JL et al. | β | 2013 | β |
| Genome-wide expression profiling of schizophrenia using a large combined cohort. | Mistry M et al. | β | 2013 | β |
| Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients. | Liu L et al. | β | 2013 | β |
| Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. | Hagihara H et al. | β | 2013 | β |
| Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits. | Kocsis B et al. | β | 2013 | β |
| Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia. | Sato C et al. | β | 2013 | β |
| Impaired impulse control is associated with a 5-HT2A receptor polymorphism in schizophrenia. | Tsuang HC et al. | β | 2013 | β |
| Integrating precision medicine in the study and clinical treatment of a severely mentally ill person. | O'Rawe JA et al. | β | 2013 | β |
| Knowledge integration in cancer: current landscape and future prospects. | Ioannidis JP et al. | β | 2013 | β |
| Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior. | Carr GV et al. | β | 2013 | β |
| Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. | Li M et al. | β | 2013 | β |
| Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. | Mistry M et al. | β | 2013 | β |
| Modernizing the systematic review process to inform comparative effectiveness: tools and methods. | Wallace BC et al. | β | 2013 | β |
| Modulation of NMDA receptor function as a treatment for schizophrenia. | Cioffi CL | β | 2013 | β |
| Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex. | Smith RM et al. | β | 2013 | β |
| Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. | Balu DT et al. | β | 2013 | β |
| Neural markers of errors as endophenotypes in neuropsychiatric disorders. | Manoach DS et al. | β | 2013 | β |
| NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. | Snyder MA et al. | β | 2013 | β |
| Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus. | English JA et al. | β | 2013 | β |
| Peripubertal viral-like challenge and social isolation mediate overlapping but distinct effects on behaviour and brain interferon regulatory factor 7 expression in the adult Wistar rat. | Lukasz B et al. | β | 2013 | β |
| Personalized medicine in psychiatry: problems and promises. | Ozomaro U et al. | β | 2013 | β |
| Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers. | LΓ³pez-RodrΓguez R et al. | β | 2013 | β |
| Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia--a potential biomarker? | Gadelha A et al. | β | 2013 | β |
| Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets. | Gong Y et al. | β | 2013 | β |
| Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum. | Novak G et al. | β | 2013 | β |
| Protein-protein interaction analysis reveals common molecular processes/pathways that contribute to risk of schizophrenia. | Luo XJ et al. | β | 2013 | β |
| Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. | Roffman JL et al. | β | 2013 | β |
| Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults. | Braskie MN et al. | β | 2013 | β |
| Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. | Witt K et al. | β | 2013 | β |
| Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs. | Costas J et al. | β | 2013 | β |
| Schizophrenia and dopamine receptors. | Seeman P | β | 2013 | β |
| Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. | Sacchetti E et al. | β | 2013 | β |
| Schizophrenia thalamus imaging: low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminals. | Seeman P | β | 2013 | β |
| Search for missing schizophrenia genes will require a new developmental neurogenomic perspective. | Kiran Kumar HB et al. | β | 2013 | β |
| Sum of parts is greater than the whole: inference of common genetic history of populations. | Utro F et al. | β | 2013 | β |
| Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders. | Carter CJ | β | 2013 | β |
| T102C polymorphism of serotonin 2A type receptor gene confers susceptibility to (early onset) schizophrenia in Han Chinese: an association study and meta-analysis. | Ni J et al. | β | 2013 | β |
| The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population. | Yang HC et al. | β | 2013 | β |
| The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. | Mowry BJ et al. | β | 2013 | β |
| The neuroimmunology of schizophrenia. | Smyth AM et al. | β | 2013 | β |
| Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. | Carter CJ | β | 2013 | β |
| What does a mouse tell us about neuregulin 1-cannabis interactions? | Karl T et al. | β | 2013 | β |
| ADHDgene: a genetic database for attention deficit hyperactivity disorder. | Zhang L et al. | β | 2012 | β |
| Adjuvant chemotherapy for breast cancer in patients with schizophrenia. | Hwang M et al. | β | 2012 | β |
| Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. | Pratt J et al. | β | 2012 | β |
| AKT/GSK3 signaling pathway and schizophrenia. | Emamian ES | β | 2012 | β |
| Analysis of blood-based gene expression signature in first-episode psychosis. | Lee J et al. | β | 2012 | β |
| An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. | Schmidt-Kastner R et al. | β | 2012 | β |
| An ICA with reference approach in identification of genetic variation and associated brain networks. | Liu J et al. | β | 2012 | β |
| An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform. | Han YJ et al. | β | 2012 | β |
| A re-review of the association between the NOTCH4 locus and schizophrenia. | Shayevitz C et al. | β | 2012 | β |
| Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia. | Lindholm CarlstrΓΆm E et al. | β | 2012 | β |
| Association between MTHFR C677T and A1298C, and MTRR A66G polymorphisms and susceptibility to schizophrenia in a Syrian study cohort. | Lajin B et al. | β | 2012 | β |
| Association between SNPs and gene expression in multiple regions of the human brain. | Kim S et al. | β | 2012 | β |
| Association of SNPs linked to increased expression of SLC1A1 with schizophrenia. | Horiuchi Y et al. | β | 2012 | β |
| Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. | Carrera N et al. | β | 2012 | β |
| AutismKB: an evidence-based knowledgebase of autism genetics. | Xu LM et al. | β | 2012 | β |
| Autworks: a cross-disease network biology application for Autism and related disorders. | Nelson TH et al. | β | 2012 | β |
| Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models. | Kvajo M et al. | β | 2012 | β |
| Beyond dopamine: glutamate as a target for future antipsychotics. | Sendt KV et al. | β | 2012 | β |
| Biological invasions: a field synopsis, systematic review, and database of the literature. | Lowry E et al. | β | 2012 | β |
| Can genetics inform the management of cognitive deficits in schizophrenia? | Vyas NS et al. | β | 2012 | β |
| CIDeR: multifactorial interaction networks in human diseases. | Lechner M et al. | β | 2012 | β |
| Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. | Costain G et al. | β | 2012 | β |
| Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes. | Vehof J et al. | β | 2012 | β |
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. | Lill CM et al. | β | 2012 | β |
| Contributions of the D-serine pathway to schizophrenia. | Labrie V et al. | β | 2012 | β |
| Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. | Ayalew M et al. | β | 2012 | β |
| Cross-cultural standardization of the South Texas Assessment of Neurocognition in India. | Cherkil S et al. | β | 2012 | β |
| D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. | Andreou D et al. | β | 2012 | β |
| Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders. | Celestino-Soper PB et al. | β | 2012 | β |
| Developing the "next generation" of genetic association databases for complex diseases. | Lill CM et al. | β | 2012 | β |
| Developmental regulation of expression of schizophrenia susceptibility genes in the primate hippocampal formation. | Favre G et al. | β | 2012 | β |
| DISC1 conditioned GWAS for psychosis proneness in a large Finnish birth cohort. | Tomppo L et al. | β | 2012 | β |
| Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. | Gilman SR et al. | β | 2012 | β |
| DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. | Alkelai A et al. | β | 2012 | β |
| D-serine and schizophrenia: an update. | Nunes EA et al. | β | 2012 | β |
| Effect of the interleukin-1Ξ² gene on dorsolateral prefrontal cortex function in schizophrenia: a genetic neuroimaging study. | FatjΓ³-Vilas M et al. | β | 2012 | β |
| Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update. | Keilhoff G et al. | β | 2012 | β |
| EnigmaVis: online interactive visualization of genome-wide association studies of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. | Novak NM et al. | β | 2012 | β |
| Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. | Peerbooms O et al. | β | 2012 | β |
| From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. | Moghaddam B et al. | β | 2012 | β |
| Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. | Uezato A et al. | β | 2012 | β |
| Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. | Yokley JL et al. | β | 2012 | β |
| Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. | Staines-Urias E et al. | β | 2012 | β |
| Genetic association study of the P300 endophenotype in schizophrenia. | Decoster J et al. | β | 2012 | β |
| Genetic factors modulating the response to stimulant drugs in humans. | Hart AB et al. | β | 2012 | β |
| Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. | Schuh-Huerta SM et al. | β | 2012 | β |
| Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. | O'Tuathaigh CM et al. | β | 2012 | β |
| Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? | Lee KW et al. | β | 2012 | β |
| Genome-wide linkage scan of antisocial behavior, depression, and impulsive substance use in the UCSF family alcoholism study. | Gizer IR et al. | β | 2012 | β |
| Glutamate receptor Ξ΄ 1 (GRID1) genetic variation and brain structure in schizophrenia. | Nenadic I et al. | β | 2012 | β |
| Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. | Coyle JT et al. | β | 2012 | β |
| Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. | Javitt DC et al. | β | 2012 | β |
| Human genetics of schizophrenia. | Claes S et al. | β | 2012 | β |
| Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. | Collins AL et al. | β | 2012 | β |
| Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder? | Schubert KO et al. | β | 2012 | β |
| Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia. | Verbrugghe P et al. | β | 2012 | β |
| Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia. | Sun J et al. | β | 2012 | β |
| Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. | Mathieson I et al. | β | 2012 | β |
| Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population. | Saetre P et al. | β | 2012 | β |
| miRNA regulation of gene expression: a predictive bioinformatics analysis in the postnatally developing monkey hippocampus. | Favre G et al. | β | 2012 | β |
| MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder. | Guo L et al. | β | 2012 | β |
| Modelling the contribution of family history and variation in single nucleotide polymorphisms to risk of schizophrenia: a Danish national birth cohort-based study. | Agerbo E et al. | β | 2012 | β |
| Molecular genetics of the psychosis phenotype. | DeRosse P et al. | β | 2012 | β |
| Multifaceted genomic risk for brain function in schizophrenia. | Chen J et al. | β | 2012 | β |
| Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families. | Logue MW et al. | β | 2012 | β |
| Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. | Jia P et al. | β | 2012 | β |
| Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110Ξ΄ inhibition as a potential therapeutic strategy. | Law AJ et al. | β | 2012 | β |
| NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. | Gonzalez-Burgos G et al. | β | 2012 | β |
| No association between catechol-O-methyltransferase polymorphisms and neurotic disorders among mainland Chinese university students. | Kou C et al. | β | 2012 | β |
| Paradox of schizophrenia genetics: is a paradigm shift occurring? | Doi N et al. | β | 2012 | β |
| Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene Γ environment interaction. | Desbonnet L et al. | β | 2012 | β |
| Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice. | Desbonnet L et al. | β | 2012 | β |
| Psychopathology and the human connectome: toward a transdiagnostic model of risk for mental illness. | Buckholtz JW et al. | β | 2012 | β |
| Psychosis Incident Cohort Outcome Study (PICOS). A multisite study of clinical, social and biological characteristics, patterns of care and predictors of outcome in first-episode psychosis. Background, methodology and overview of the patient sample. | Lasalvia A et al. | β | 2012 | β |
| Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1. | Gokhale A et al. | β | 2012 | β |
| Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. | Williams AA et al. | β | 2012 | β |
| Relationship of a variant in the NTRK1 gene to white matter microstructure in young adults. | Braskie MN et al. | β | 2012 | β |
| Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. | Ellingrod VL et al. | β | 2012 | β |
| Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese. | Zheng C et al. | β | 2012 | β |
| Searching joint association signals in CATIE schizophrenia genome-wide association studies through a refined integrative network approach. | Jia P et al. | β | 2012 | β |
| Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples. | Gladwin TE et al. | β | 2012 | β |
| Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology. | O'Tuathaigh CM et al. | β | 2012 | β |
| SynaptomeDB: an ontology-based knowledgebase for synaptic genes. | Pirooznia M et al. | β | 2012 | β |
| Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. | Theodoratou E et al. | β | 2012 | β |
| Systems biology, bioinformatics, and biomarkers in neuropsychiatry. | Alawieh A et al. | β | 2012 | β |
| Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study. | Liu Q et al. | β | 2012 | β |
| The androgen receptor facilitates inhibition of human dopamine transporter (DAT1) reporter gene expression by HESR1 and HESR2 via the variable number of tandem repeats. | Kanno K et al. | β | 2012 | β |
| The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. | Cukier HN et al. | β | 2012 | β |
| The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. | Kaushik M et al. | β | 2012 | β |
| Timing as a window on cognition in schizophrenia. | Ward RD et al. | β | 2012 | β |
| Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining. | Wallace BC et al. | β | 2012 | β |
| Toxoplasma gondii and other risk factors for schizophrenia: an update. | Torrey EF et al. | β | 2012 | β |
| Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. | Wu JQ et al. | β | 2012 | β |
| ZNF804A and schizophrenia susceptibility in Asian populations. | Li M et al. | β | 2012 | β |
| ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. | Girgenti MJ et al. | β | 2012 | β |
| A comprehensive network and pathway analysis of candidate genes in major depressive disorder. | Jia P et al. | β | 2011 | β |
| A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals. | Roffman JL et al. | β | 2011 | β |
| All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. | Seeman P | β | 2011 | β |
| Alterations in the expression of neuronal chloride transporters may contribute to schizophrenia. | Kalkman HO | β | 2011 | β |
| Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. | Zhan L et al. | β | 2011 | β |
| A methodology based on molecular interactions and pathways to find candidate genes associated to diseases: its application to schizophrenia and Alzheimer's disease. | OchagavΓa ME et al. | β | 2011 | β |
| Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia. | Lai IC et al. | β | 2011 | β |
| Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project. | Mu XJ et al. | β | 2011 | β |
| A new web-based Schizophrenia Library--evidence compiled and graded systematically. | Matheson SL et al. | β | 2011 | β |
| Animal models of schizophrenia. | Jones CA et al. | β | 2011 | β |
| An improved kinetic model for the acetone-butanol-ethanol pathway of Clostridium acetobutylicum and model-based perturbation analysis. | Li RD et al. | β | 2011 | β |
| An integrative functional genomics approach for discovering biomarkers in schizophrenia. | Vawter MP et al. | β | 2011 | β |
| ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype. | Vila-Rodriguez F et al. | β | 2011 | β |
| A population genetic approach to mapping neurological disorder genes using deep resequencing. | Myers RA et al. | β | 2011 | β |
| A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis. | Varvarigou V et al. | β | 2011 | β |
| Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses. | Lee KY et al. | β | 2011 | β |
| Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. | Zhang C et al. | β | 2011 | β |
| Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders. | Sarnyai Z et al. | β | 2011 | β |
| Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. | Beaulieu JM et al. | β | 2011 | β |
| Biomarkers in development of psychotropic drugs. | Wiedemann K | β | 2011 | β |
| Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene. | Mullin AP et al. | β | 2011 | β |
| Cognitive control deficits in schizophrenia: mechanisms and meaning. | Lesh TA et al. | β | 2011 | β |
| Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population. | Chen P et al. | β | 2011 | β |
| Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia. | Tang B et al. | β | 2011 | β |
| Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia. | McNally JM et al. | β | 2011 | β |
| Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. | Chatzinasiou F et al. | β | 2011 | β |
| Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients. | Molina V et al. | β | 2011 | β |
| Converging evidence implicates the dopamine D3 receptor gene in vulnerability to schizophrenia. | Zhang F et al. | β | 2011 | β |
| Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. | Benneyworth MA et al. | β | 2011 | β |
| DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. | Blasi G et al. | β | 2011 | β |
| D-serine: the right or wrong isoform? | Fuchs SA et al. | β | 2011 | β |
| Dysbindin-1 genotype effects on emotional working memory. | Wolf C et al. | β | 2011 | β |
| Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. | Andreou D et al. | β | 2011 | β |
| Elevated DISC1 transcript levels in PBMCs during acute psychosis in patients with schizophrenia. | Olincy A et al. | β | 2011 | β |
| Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. | Pidsley R et al. | β | 2011 | β |
| Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects. | Fukui N et al. | β | 2011 | β |
| Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. | Ziats MN et al. | β | 2011 | β |
| Folate supplementation in schizophrenia: a possible role for MTHFR genotype. | Hill M et al. | β | 2011 | β |
| Gene and miRNA expression profiles in autism spectrum disorders. | Ghahramani Seno MM et al. | β | 2011 | β |
| Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia. | Gysin R et al. | β | 2011 | β |
| Genetic epidemiology with a capital E, ten years after. | Khoury MJ et al. | β | 2011 | β |
| Genetics in psychiatry: are the promises met? | Bondy B | β | 2011 | β |
| Genetics of schizophrenia: new findings and challenges. | Gejman PV et al. | β | 2011 | β |
| Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. | Zhang B et al. | β | 2011 | β |
| Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. | Buizer-Voskamp JE et al. | β | 2011 | β |
| Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. | Yue WH et al. | β | 2011 | β |
| Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. | Costas J et al. | β | 2011 | β |
| Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus. | Adams W et al. | β | 2011 | β |
| Identification of blood biomarkers for psychosis using convergent functional genomics. | Kurian SM et al. | β | 2011 | β |
| Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. | Alkelai A et al. | β | 2011 | β |
| Increased exonic de novo mutation rate in individuals with schizophrenia. | Girard SL et al. | β | 2011 | β |
| Increased expression of dysbindin-1A leads to a selective deficit in NMDA receptor signaling in the hippocampus. | Jeans A et al. | β | 2011 | β |
| Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex. | Nixon DC et al. | β | 2011 | β |
| Is Ankyrin a genetic risk factor for psychiatric phenotypes? | Gella A et al. | β | 2011 | β |
| Is DNA methylation responsible for immune system dysfunction in schizophrenia? | Khojasteh-Fard M et al. | β | 2011 | β |
| Linkage and association on 8p21.2-p21.1 in schizophrenia. | Fallin MD et al. | β | 2011 | β |
| Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. | Li CY et al. | β | 2011 | β |
| Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? | Peerbooms OL et al. | β | 2011 | β |
| Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. | Miller B et al. | β | 2011 | β |
| Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: a combined analysis of independent samples. | Saetre P et al. | β | 2011 | β |
| MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. | Lai CY et al. | β | 2011 | β |
| Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience. | Ward RD et al. | β | 2011 | β |
| Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain. | Strick CA et al. | β | 2011 | β |
| Monoamine transporters: vulnerable and vital doorkeepers. | Lin Z et al. | β | 2011 | β |
| MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study. | Roffman JL et al. | β | 2011 | β |
| Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology. | RΓΌnker AE et al. | β | 2011 | β |
| Network-assisted Causal Gene Detection in Genome-wide Association Studies: An Improved Module Search Algorithm. | Jia P et al. | β | 2011 | β |
| Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. | Balu DT et al. | β | 2011 | β |
| No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. | TabarΓ©s-Seisdedos R et al. | β | 2011 | β |
| PharmGKB summary: dopamine receptor D2. | Mi H et al. | β | 2011 | β |
| Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. | Jablensky A et al. | β | 2011 | β |
| Polymorphisms of methylenetetrahydrofolate reductase are not a risk factor for Kawasaki disease in the Korean population. | Yoon KL et al. | β | 2011 | β |
| Possible association of the semaphorin 3D gene (SEMA3D) with schizophrenia. | Fujii T et al. | β | 2011 | β |
| Prioritization of epilepsy associated candidate genes by convergent analysis. | Jia P et al. | β | 2011 | β |
| Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells. | Zearfoss NR et al. | β | 2011 | β |
| Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. | Tarabeux J et al. | β | 2011 | β |
| Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. | Remington G et al. | β | 2011 | β |
| Schizophrenia genetics: where next? | Kim Y et al. | β | 2011 | β |
| Schizophrenia: treatment targets beyond monoamine systems. | Ibrahim HM et al. | β | 2011 | β |
| Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis. | Kishi T et al. | β | 2011 | β |
| Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. | Glatt SJ et al. | β | 2011 | β |
| Structural and functional impairments of polysialic acid by a mutated polysialyltransferase found in schizophrenia. | Isomura R et al. | β | 2011 | β |
| Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location. | Talbot K et al. | β | 2011 | β |
| The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. | Roussos P et al. | β | 2011 | β |
| The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons. | Allison JG et al. | β | 2011 | β |
| The genetics of cognitive impairment in schizophrenia: a phenomic perspective. | Bilder RM et al. | β | 2011 | β |
| The genetic validation of heterogeneity in schizophrenia. | Tsutsumi A et al. | β | 2011 | β |
| The impact of multifunctional genes on "guilt by association" analysis. | Gillis J et al. | β | 2011 | β |
| The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. | Roussos P et al. | β | 2011 | β |
| The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. | Millar A et al. | β | 2011 | β |
| The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse. | Larimore J et al. | β | 2011 | β |
| Translating glutamate: from pathophysiology to treatment. | Javitt DC et al. | β | 2011 | β |
| A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: collaborative of 53 studies with 20,435 cases and 23,674 controls. | Xu M et al. | β | 2010 | β |
| Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption. | Kirby BP et al. | β | 2010 | β |
| A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. | Dubertret C et al. | β | 2010 | β |
| An association study between the dymeclin gene and schizophrenia in the Japanese population. | Yazaki S et al. | β | 2010 | β |
| An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population. | Fan H et al. | β | 2010 | β |
| Animal models of neuropsychiatric disorders. | Nestler EJ et al. | β | 2010 | β |
| A novel microRNA and transcription factor mediated regulatory network in schizophrenia. | Guo AY et al. | β | 2010 | β |
| APOE epsilon4 and cognitive dysfunction in multiple sclerosis: a review. | Ghaffar O et al. | β | 2010 | β |
| A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. | Simpson EH et al. | β | 2010 | β |
| A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. | Lencz T et al. | β | 2010 | β |
| Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia. | Vares M et al. | β | 2010 | β |
| Association of DISC1 gene with schizophrenia in families from two distinct French and Algerian populations. | Lepagnol-Bestel AM et al. | β | 2010 | β |
| Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. | RΓ©thelyi JM et al. | β | 2010 | β |
| Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. | Coyle JT et al. | β | 2010 | β |
| Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. | Nicodemus KK et al. | β | 2010 | β |
| Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia. | Eisenberg DP et al. | β | 2010 | β |
| Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. | Bassett AS et al. | β | 2010 | β |
| Common genetic variations in TPH1/TPH2 genes are not associated with schizophrenia in Japanese population. | Shiroiwa K et al. | β | 2010 | β |
| Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. | Johansson S et al. | β | 2010 | β |
| Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. | Saus E et al. | β | 2010 | β |
| COMT genotype and its role on hippocampal-prefrontal regions in declarative memory. | Krach S et al. | β | 2010 | β |
| Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population. | Xu M et al. | β | 2010 | β |
| Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia". | Lill CM et al. | β | 2010 | β |
| Credible genetic associations? | MunafΓ² MR | β | 2010 | β |
| Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia. | Sand PG et al. | β | 2010 | β |
| Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. | Watanabe Y et al. | β | 2010 | β |
| De novo truncating mutation in Kinesin 17 associated with schizophrenia. | Tarabeux J et al. | β | 2010 | β |
| Detection of susceptibility genes as modifiers due to subgroup differences in complex disease. | Bergen SE et al. | β | 2010 | β |
| Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1. | Walsh J et al. | β | 2010 | β |
| Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. | Hayashi-Takagi A et al. | β | 2010 | β |
| DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients--support for the glutamate hypothesis of schizophrenias. | Fallgatter AJ et al. | β | 2010 | β |
| Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice. | Yoon S et al. | β | 2010 | β |
| Epigenetics and biomarkers in the staging of neuropsychiatric disorders. | Archer T et al. | β | 2010 | β |
| Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence. | Torri F et al. | β | 2010 | β |
| Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia. | GarcΓa-Miss Mdel R et al. | β | 2010 | β |
| From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. | Wermter AK et al. | β | 2010 | β |
| Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study. | Paul-Samojedny M et al. | β | 2010 | β |
| Further evidence that methylenetetrahydrofolate reductase A1298C polymorphism is a risk factor for schizophrenia. | Zhang C et al. | β | 2010 | β |
| Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis. | Sun J et al. | β | 2010 | β |
| Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. | Bertolino A et al. | β | 2010 | β |
| Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency. | Cheli VT et al. | β | 2010 | β |
| Genetics in psychiatry: common variant association studies. | Buxbaum JD et al. | β | 2010 | β |
| Genetics in schizophrenia: where are we and what next? | Tiwari AK et al. | β | 2010 | β |
| Genetics of human social behavior. | Ebstein RP et al. | β | 2010 | β |
| Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data. | Yoshimi A et al. | β | 2010 | β |
| Genome-wide association studies: a primer. | Corvin A et al. | β | 2010 | β |
| Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B). | Hokyo A et al. | β | 2010 | β |
| Influence of maternal MTHFR A1298C polymorphism on the risk in offspring of schizophrenia. | Zhang C et al. | β | 2010 | β |
| Meta-analysis of genetic variation in DTNBP1 and general cognitive ability. | Zhang JP et al. | β | 2010 | β |
| MicroRNA dysregulation in psychiatric disease. | Miller BH et al. | β | 2010 | β |
| Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. | van den Buuse M | β | 2010 | β |
| Molecules, signaling, and schizophrenia. | Kvajo M et al. | β | 2010 | β |
| MTHFR and risk of metabolic syndrome in patients with schizophrenia. | van Winkel R et al. | β | 2010 | β |
| MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study. | van Winkel R et al. | β | 2010 | β |
| Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. | O'Tuathaigh CM et al. | β | 2010 | β |
| Mutant mouse models: phenotypic relationships to domains of psychopathology and pathobiology in schizophrenia. | O'Tuathaigh CM et al. | β | 2010 | β |
| Nature and nurture in neuropsychiatric genetics: where do we stand? | Dick DM et al. | β | 2010 | β |
| New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? | Nieratschker V et al. | β | 2010 | β |
| N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? | Kantrowitz JT et al. | β | 2010 | β |
| No association between DAO and schizophrenia in a Japanese patient population: a multicenter replication study. | Ohnuma T et al. | β | 2010 | β |
| No association between MTHFR C677T or A1298C and age at onset of schizophrenia. | Peerbooms O et al. | β | 2010 | β |
| No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample. | Bergen SE et al. | β | 2010 | β |
| No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. | Zhang C et al. | β | 2010 | β |
| Penetrance for copy number variants associated with schizophrenia. | Vassos E et al. | β | 2010 | β |
| Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort. | Glaser B et al. | β | 2010 | β |
| Pilot study on schizophrenia in Sardinia. | Ott J et al. | β | 2010 | β |
| Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. | Bonvicini C et al. | β | 2010 | β |
| Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophrenia. | Bergman O et al. | β | 2010 | β |
| Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. | Siontis KC et al. | β | 2010 | β |
| REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. | Van Winkel R et al. | β | 2010 | β |
| Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation. | Amato R et al. | β | 2010 | β |
| Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. | Petrovsky N et al. | β | 2010 | β |
| Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. | Jiang Y et al. | β | 2010 | β |
| Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. | Karam CS et al. | β | 2010 | β |
| SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. | Loe-Mie Y et al. | β | 2010 | β |
| SZGR: a comprehensive schizophrenia gene resource. | Jia P et al. | β | 2010 | β |
| Testing for genetic association between the ZDHHC8 gene locus and susceptibility to schizophrenia: An integrated analysis of multiple datasets. | Xu M et al. | β | 2010 | β |
| The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. | Baharnoori M et al. | β | 2010 | β |
| The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. | Castaldi PJ et al. | β | 2010 | β |
| The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. | Ribbe K et al. | β | 2010 | β |
| The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: case-control studies and an updated meta-analysis. | Nunokawa A et al. | β | 2010 | β |
| The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: a meta-analysis. | Tsai HT et al. | β | 2010 | β |
| The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. | Ghiani CA et al. | β | 2010 | β |
| [The genetics of schizophrenia: back to the clinic?]. | Krebs MO et al. | β | 2010 | β |
| The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. | Vinkers CH et al. | β | 2010 | β |
| The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. | Verrall L et al. | β | 2010 | β |
| The origins and evolution of genetic disease risk in modern humans. | Crespi BJ | β | 2010 | β |
| The role of genetics in the etiology of schizophrenia. | Gejman PV et al. | β | 2010 | β |
| The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy. | Moore H | β | 2010 | β |
| The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. | McHugh RK et al. | β | 2010 | β |
| The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysis. | Saetre P et al. | β | 2010 | β |
| Understanding the complex etiologies of developmental disorders: behavioral and molecular genetic approaches. | Willcutt EG et al. | β | 2010 | β |
| A CitationRank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction. | Yang L et al. | β | 2009 | β |
| Advances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics? | Collier DA et al. | β | 2009 | β |
| A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. | Potkin SG et al. | β | 2009 | β |
| Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study. | Glatt SJ et al. | β | 2009 | β |
| Alzheimer's disease genetics current status and future perspectives. | Bertram L | β | 2009 | β |
| A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. | Sun J et al. | β | 2009 | β |
| Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. | Ueno H et al. | β | 2009 | β |
| A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. | Huffaker SJ et al. | β | 2009 | β |
| Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. | Galehdari H et al. | β | 2009 | β |
| Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia. | Zai CC et al. | β | 2009 | β |
| A two-stage case-control association study of PADI2 with schizophrenia. | Watanabe Y et al. | β | 2009 | β |
| Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. | Lin L et al. | β | 2009 | β |
| Building a knowledge base on genetic variation and cancer risk through field synopses. | Yesupriya A et al. | β | 2009 | β |
| Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants. | Forero DA et al. | β | 2009 | β |
| Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. | Betcheva ET et al. | β | 2009 | β |
| Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. | TabarΓ©s-Seisdedos R et al. | β | 2009 | β |
| Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p. | Lin SH et al. | β | 2009 | β |
| Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. | Tang J et al. | β | 2009 | β |
| Epigenetic mediation of environmental influences in major psychotic disorders. | Rutten BP et al. | β | 2009 | β |
| Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population. | Vijayan NN et al. | β | 2009 | β |
| Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. | Martin MV et al. | β | 2009 | β |
| Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. | Bertolino A et al. | β | 2009 | β |
| GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. | Charych EI et al. | β | 2009 | β |
| Genetic and environmental pathways to complex diseases. | Gohlke JM et al. | β | 2009 | β |
| Genetic polymorphisms in dopamine- and serotonin-related genes and treatment responses to risperidone and perospirone. | Tsutsumi A et al. | β | 2009 | β |
| Genetics of psychosis; insights from views across the genome. | O'Donovan MC et al. | β | 2009 | β |
| Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. | Khoury MJ et al. | β | 2009 | β |
| Genomewide association studies: history, rationale, and prospects for psychiatric disorders. | Psychiatric GWAS Consortium Coordinating Committee et al. | β | 2009 | β |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | β | 2009 | β |
| Genome-wide scan for signatures of human population differentiation and their relationship with natural selection, functional pathways and diseases. | Amato R et al. | β | 2009 | β |
| Genomic sister-disorders of neurodevelopment: an evolutionary approach. | Crespi B et al. | β | 2009 | β |
| Genotype-phenotype databases: challenges and solutions for the post-genomic era. | Thorisson GA et al. | β | 2009 | β |
| Haplotype frequencies at the DRD2 locus in populations of the East European Plain. | Flegontova OV et al. | β | 2009 | β |
| HGVbaseG2P: a central genetic association database. | Thorisson GA et al. | β | 2009 | β |
| Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting. | Zhang Y et al. | β | 2009 | β |
| Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. | Ioannidis JP | β | 2009 | β |
| Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. | Risch N et al. | β | 2009 | β |
| Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. | Koga M et al. | β | 2009 | β |
| Meta-analysis in genome-wide association studies. | Zeggini E et al. | β | 2009 | β |
| Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. | Okochi T et al. | β | 2009 | β |
| Modeling cognitive endophenotypes of schizophrenia in mice. | Kellendonk C et al. | β | 2009 | β |
| Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. | Mellios N et al. | β | 2009 | β |
| Mutant models for genes associated with schizophrenia. | Desbonnet L et al. | β | 2009 | β |
| Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. | Cox MM et al. | β | 2009 | β |
| New findings from genetic association studies of schizophrenia. | Williams HJ et al. | β | 2009 | β |
| One-carbon metabolism and schizophrenia: current challenges and future directions. | Krebs MO et al. | β | 2009 | β |
| Paternal age as a risk factor for schizophrenia: how important is it? | Torrey EF et al. | β | 2009 | β |
| Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. | Doi N et al. | β | 2009 | β |
| Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain. | Zill P et al. | β | 2009 | β |
| Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. | Tan HY et al. | β | 2009 | β |
| Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat. | BΓΆhm SV et al. | β | 2009 | β |
| Recent advances in postmortem pathology and neurochemistry in schizophrenia. | Dean B et al. | β | 2009 | β |
| Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. | Stober G et al. | β | 2009 | β |
| Schizophrenia genetics: new insights from new approaches. | Williams HJ et al. | β | 2009 | β |
| Schizophrenia genomics and proteomics: are we any closer to biomarker discovery? | Lakhan SE et al. | β | 2009 | β |
| Schizophrenia: the "BLOC" may be in the endosomes. | Ryder PV et al. | β | 2009 | β |
| Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. | Alaerts M et al. | β | 2009 | β |
| Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008. | Bergen S et al. | β | 2009 | β |
| Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. | Quednow BB et al. | β | 2009 | β |
| Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip). | Pedrosa E et al. | β | 2009 | β |
| Systematic reviews of genetic association studies. Human Genome Epidemiology Network. | Sagoo GS et al. | β | 2009 | β |
| The contribution of epidemiology to defining the most appropriate approach to genetic research on schizophrenia. | Tosato S et al. | β | 2009 | β |
| The dopamine hypothesis of schizophrenia: version III--the final common pathway. | Howes OD et al. | β | 2009 | β |
| The dystrobrevin-binding protein 1 gene: features and networks. | Guo AY et al. | β | 2009 | β |
| The genetics of schizophrenia. | Bertolino A et al. | β | 2009 | β |
| The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research. | Talbot K | β | 2009 | β |
| Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism. | Roussos P et al. | β | 2009 | β |
| Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. | Miller CL et al. | β | 2009 | β |
| Update on key previously proposed candidate genes for schizophrenia. | Schwab SG et al. | β | 2009 | β |
| What we know: findings that every theory of schizophrenia should explain. | MacDonald AW et al. | β | 2009 | β |
| Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level. | Stefanis NC et al. | β | 2008 | β |
| Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. | Yu W et al. | β | 2008 | β |
| Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new. | Porteous D | β | 2008 | β |
| Genetic research in schizophrenia: new tools and future perspectives. | Bertram L | β | 2008 | β |
| Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. | Mudge J et al. | β | 2008 | β |
| MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. | Roffman JL et al. | β | 2008 | β |
| The dice are rolling for schizophrenia genetics. | Sullivan PF | β | 2008 | β |
| Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation. | Weiss KM | β | 2008 | β |
| Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. | Bach ME et al. | β | 2008 | β |